Test Price
2,800 AED✅ Home Collection Available
PINK1 Gene (PARK6) Parkinson Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين PINK1 (بارك6) لمرض باركنسون بتقنية التسلسل الجيني عالي الإنتاجية في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – Clinical Certainty & UAE Compliance
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by a DHA-licensed neurologist.
- Insurance: Direct Billing Verification via WhatsApp: +971 54 548 8731.
ملخص تنفيذي: يقدم هذا الفحص الجيني المتطور تسلسلاً كاملاً لجين PINK1 المرتبط بالباركنسون المبكر، بدقة تشخيصية تصل إلى 99.9%، مع خدمة سحب منزلي طبقاً للمواصفات الدولية وامتثال كامل لقانون مكافحة الأمراض السارية في الدولة.
Regulatory Compliance & Data Privacy
Fully aligned with Federal Decree-Law No. 41 of 2024 (Art. 87), CDS Law 2026 (Minors Protection), and UAE PDPL. All genetic data is encrypted, stored within UAE sovereign clouds, and never shared without explicit consent.
Critical Safety Exclusion & Red Flags
Exclusion Criteria: Individuals under 18 years without court‑appointed guardian consent; patients with uncontrolled coagulopathy or acute febrile illness at time of draw.
Emergency Red Flags: If you experience sudden worsening of tremor, unexplained falls, hallucinations, or severe dyskinesia, stop the home collection request and proceed to the nearest ER immediately.
Overview of the PINK1 Genetic Test
This test uses Next‑Generation Sequencing (NGS) to analyze the entire coding region of the PINK1 gene, the PARK6 locus linked to autosomal recessive early‑onset Parkinson’s disease. It detects single nucleotide variants, insertions/deletions, and copy number changes with unmatched precision, helping neurologists confirm a molecular diagnosis and guide long‑term surveillance. يُستخدم هذا التحليل للكشف عن الطفرات المسببة لمرض باركنسون المبكر، ويعين الأطباء في وضع خطة علاجية شخصية.
| Feature | Our PINK1 NGS Test | Closest Alternative (Targeted Panel) |
|---|---|---|
| Methodology | Full‑gene NGS with CNV analysis | Limited mutation hotspot detection |
| Coverage | All exons & splice sites ±20 bp | Selected common pathogenic variants only |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Diagnostic Yield (Early‑Onset PD) | Up to 10% in recessive families | 2–4% |
| Price (AED) | 2800 | 2400 |
Physician Insight & Safety Protocol
“As a DHA‑licensed neurologist, I remind every patient that a genetic result is a piece of a larger clinical puzzle. This test reveals inherited susceptibility, not a destiny; always combine it with a thorough neurological examination, family history, and a multidisciplinary care plan. Please never alter your medications without consulting your treating physician.” – Dr. PRABHAKAR REDDY, DHA License: 61713011
Medication Warning:
Do not discontinue prescribed medication (e.g., levodopa, dopamine agonists) without consulting your doctor. Abrupt withdrawal may cause neuroleptic malignant‑like syndrome or severe parkinsonism crisis.
Patient FAQ & Clinical Guidance
1. What exactly does the PINK1 gene test detect?
This NGS assay identifies pathogenic variants in the PINK1 gene that cause early‑onset Parkinson’s disease, including missense, nonsense, and copy number changes, thereby enabling a definitive molecular diagnosis and informing carrier screening for family members.
يكشف هذا الاختبار عن الطفرات المسببة للمرض في جين PINK1 المرتبط بباركنسون المبكر، مما يوفر تشخيصاً جزيئياً دقيقاً ويساعد في فحص أفراد العائلة.
2. Who should consider this test?
Individuals with onset of parkinsonian symptoms before age 40, especially when there is a family history of the disease or consanguinity, benefit most from this test because PINK1 mutations are a major contributor to autosomal recessive juvenile Parkinson’s.
يستفيد من هذا التحليل الأشخاص الذين ظهرت عليهم أعراض باركنسون قبل سن الأربعين، خصوصاً مع وجود تاريخ عائلي أو زواج الأقارب.
3. How is the sample collected and is the process painful?
One peripheral blood draw (or a simple FTA card spot) is collected by a certified phlebotomist during a 15‑minute home visit; the procedure feels like a routine blood with minimal discomfort and zero downtime.
يتم سحب عينة دم وريدي بسيطة أو بقعة على بطاقة FTA خلال زيارة منزلية تستغرق 15 دقيقة، وهي تشبه تحليل الدم العادي ولا تسبب ألماً يُذكر.
ISO 9001:2015 Certified Process – Cert: INT/EGQ/2509DA/3139
Facility License: 9834453. All laboratory work is performed under stringent quality controls meeting 2026 DHA/MOHAP standards.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians